Health Condition 1: I52- Other heart disorders in diseasesclassified elsewhere
Conditions
Interventions
Intervention1: CAD + DM: ok
Intervention2: NIL: NIL
Control Intervention1: NIL: NIL
Control Intervention2: NIL: NIL
Control Intervention3: Group 1:(HC)Healthy control group.
Group 2:(DM)Type 2 Diabete
Sponsors
Richa Negi
Eligibility
Inclusion criteria
Inclusion criteria: 1.Type 2 Diabetes Diagnosis: participant must be diagnosed with type 2 diabetes(confirmed by clinical criteria or medical records. 2.Age range: studies may focus on specific age groups,such as adult aged 40-70 years,as CAD risk increases with age. 3.Presence of CAD or carddiovascular risk: Participants should either have CAD (diagnosed through imaging or clinical signs)or be at high risk of devloping CAD,based on risk factor like high blood pressure,obesity,or smoking. 4.Measurement of Biochemical Markers: .studies that measures specific biochemical markers associated with CAD markers(homocysteine,lipoprotein a,apolipoproteins 5.Study design: cross sectional,observational study.
Exclusion criteria
Exclusion criteria: 1.Other type of Diabetes: .Individual with type 1 diabetes, gestational diabetes, or other non-type 2 diabetes condition are excluded to focus on type 2 diabetes specifically. 2-Non cardiovascular disease: participants with condition such as chronic kidney disease, liver dysfunction, cancer, or other major comorbidities that might confound the relationship between CAD and biochemical markers in type 2 diabetes. 3-Acute or uncontrolled illness: Exclusion of individuals with acute infections, acute myocardial infarction, or other condition that might temporarily elevate biochemical markers unrelated to chronic CAD. 4-Pregnancy: Pregnant women are typically excluded due to the physiological and hormonal changes during pregnancy that can affect biochemical markers and CAD risk. 5-Medication: Individuals on certain medications(e.g,corticosteroids,high-dose statins, or immunosuppressive drugs)that might influence CAD markers in ways unrelated to the diabetes condition may be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identication of specific biochemical markers associated with the presence or risk of Coronary artery disease in type 2 diabetes patients. Lipid profile and glycemic controlTimepoint: 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalance of Coronary artery disease in study population. Association between clinical parameters & biochemical markers.Timepoint: 8 weeks | — |
Countries
India
Contacts
Public ContactDr Pooja Naudiyal
SBSU Balawala Dehradoon
Outcome results
None listed